Showing results (2561-2570 of 3,027) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|February 7, 2025
Clinical and Prognostic Implications of an Alternative Splicing-related Risk Model Based on TP53 Status in Breast CancerXinrui Wang, Zhoujie Ye, Liping Zhou, et al.Current Pharmaceutical Biotechnology|June 26, 2024
Exploring Marine Alkaloids: A Natural Approach to Cancer TreatmentSonia Singh, Surendra Kumar, Amit Kumar Singh, et al.Current Pharmaceutical Biotechnology|June 26, 2024
Significant Interaction between Melatonin and Titanium Bone Implants: Available Evidence and Future Research DirectionsAzam Hosseinzadeh, Abolfazl Bagherifard, Mohammad Sheibani, et al.Current Pharmaceutical Biotechnology|June 21, 2024
Articulating the Pharmacological and Nanotechnological Aspects of Genistein: Current and Future ProspectivesKeshav Bansal, Vanshita Singh, Samiksha Mishra, et al.Current Pharmaceutical Biotechnology|June 24, 2024
Drug Targeting and Nanotherapeutic Advancement in the Treatment of Rheumatoid Arthritis: Recent Progress in Drug Delivery SystemsRohitas DeshmukhCurrent Pharmaceutical Biotechnology|June 23, 2006
Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemiasLaure Deville, Josette Hillion, Michel Lanotte, et al.Current Pharmaceutical Biotechnology|June 23, 2006
Proteomics of p53 in diagnostics and therapy of acute myeloid leukemiaNina Anensen, Ingvild Haaland, Clive D'Santos, et al.Current Pharmaceutical Biotechnology|June 23, 2006
Does isoform diversity explain functional differences in the 14-3-3 protein family?E Kjarland, T J Keen, R KleppeCurrent Pharmaceutical Biotechnology|August 22, 2006
Accounting for triplet and saturation effects in FCS measurementsLloyd M Davis, Guoqing ShenCurrent Pharmaceutical Biotechnology|August 22, 2006
The congenital cytomegalovirus infection: virus-host interaction for defense and transmissionGabriele Halwachs-BaumannPageof 303